Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain
the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in
Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles
and JavaScript.
Project covering one-fifth of the country’s population is one of the largest-ever efforts to share results on genetic health risks with research participants.
As the patents on various weight-loss drugs near expiry, companies in India and China are vying to make lower-cost versions that will widen access to such treatments.
After several controversial drug approvals, the US Food and Drug Administration is mulling over changes to its advisory panels, which include researchers and others.